MindMaze Therapeutics Holding SA

Fr 0.13As of Sun 8 Nov 2026, 12:00 UTC
SWX:MMTXHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap Fr 22.81M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 0.135
0.91%
(46.37%)
Hold 9|9|7|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
—
—
—
—
(4.87%)
0.43%
(3.42%)
2.11%
RevenueFr M
1.931
1.931
1.908
2.011
8.35%
8.30%
1.86%
5.51%
Peers (US$27.98M)
Cap (US$)
PE
59.55M
—
15.74M
—
28.20M
4.176x
Capital
TTM
5Y
10Y
Leveragex
3.158
(0.155)
(0.143)
EBIT/Intx
1.086
0.143
0.135
Own earn%
149.41
48.74
63.79
Sh yield%
41.51
54.75
49.52
Owners
Insiders/Inst%
8.17
71.54
Short interest%
5.26
SBC / revenue%
1.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
14–24
$1 testx
—
Incr. ROIC%
5